Insider buying last 90 days
No open-market insider purchases were filed for TEM in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Tempus AI closed at $84.44 on 9 November 2026, +11% on the day. The price sits above both the 50-day ($71.73) and 200-day ($57.23) moving averages, inside a 52-week range of $40.77 to $89.09. The GekkoIndex reads 52.7, in the Neutral zone, down 0.9 points over five sessions. Gekko Fair Value is $75.95, so the price is 11.2% above it.
The next earnings report is due on 23 February 2027, 100 days away (after close). Over the last 8 reports the company beat the earnings estimate 7 times, with an average move of 7% across the report. Over the last 30 days there were 7 unusual options signals.
14 firms rate the stock: 8 buy, 6 hold and 0 sell, with a consensus target of $82.89. A typical daily move is about 8.2%, and a typical 20-day move about 14.9%. On the swing-trade checklist, 2 items read supportive and 2 read as a headwind (fair value, smart money).
A plain summary of the figures as of the Nov 9, 2026 close.
Tempus AI scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Averages disagree
Close $71.60 sits between the 50-day ($72.84) and 200-day ($57.45) averages, or the averages disagree.
See the chart60.5, Accumulation
Reading 60.5 is in the Accumulation zone.
See the GekkoIndex10.0% below
Price is 10% below Gekko Fair Value (more than 5% below).
See fair valueLeans bearish
Last 30 days: 6 unusual options signals.
See smart moneyReports in 100 days
Next report Feb 23, 2027, 100 days away — outside a typical 20-trading-day hold.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Tempus AI closed at $71.60 on Nov 13, 2026, +0.7% over the past year, inside a 52-week range of $40.77 to $89.09.
Use the left and right arrow keys to read daily values.
Put TEM on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Tempus AI builds technology for healthcare providers, connecting clinicians to laboratory diagnostics, data analytics and a broad library of multimodal patient information. Its platform links a doctor's desktop directly to testing capabilities, and the company is recognized for tools such as Hub, an application that guides physicians through next-generation sequencing tests from start to finish, and Lens, used for precision research in the life sciences.
The company's offerings extend across diagnostics, including sequencing, PCR profiling and pathology testing, along with specialized assays for tumor and blood cancer analysis, inherited conditions, and psychiatric pharmacogenomics. It also licenses de-identified clinical and molecular data through a product called Insights, models tumor behavior through Organoids, matches patients to clinical trials, and runs an AI platform called Next alongside an algorithm-based diagnostics tool named Algos. Tempus AI works with pharmaceutical and biotechnology partners such as AstraZeneca, Pathos AI, GlaxoSmithKline, Merck and Recursion Pharmaceuticals, and it collaborates with Blood Cancer United on a pediatric leukemia registry.
Founded in 2015 under the name Tempus Labs before adopting its current name in 2023, the company is based in Chicago, Illinois. Its shares are listed on the NASDAQ under the ticker TEM.
Tempus AI’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.5, in the Accumulation zone, up 3.4 points over five sessions.
Up 3.4 points over five sessions, from the Neutral zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 38 | +2.8% | +19.7% | ||
| Accumulation (current zone) | 203 | +3.9% | +15.3% | ||
| Neutral | 313 | +0.4% | +0.4% | ||
| Distribution | 42 | −0.3% | −10.0% | ||
| Selling | 1 | Too few readings yet | |||
Average TEM share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Tempus AI trades 10.0% below Gekko Fair Value of $79.53, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Tempus AI shares are worth, recalculated every trading day.
$79.53
Gekko Fair Value, Nov 14, 2026
10.0% Undervalued
At the end of Aug 2026 the price was 4.5% above the estimate.
No open-market insider purchases were filed for Tempus AI, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for TEM in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in TEM were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Tempus AI has been buying back its own shares.
From company filings.
6signals, 43% of the flagged premium in calls.
Latest: Bearish flow on Nov 7, $316K in unusual premium.
1of the funds Gekko tracks holds TEM.
Tempus AI reports on Feb 23, 2027, after the close (100 days away), and beat the EPS estimate in 7 of its last 8 reports.
Feb 23, 2027
Expected after the close, 100 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 2, 2026 | $0.07 est −$0.09 | $411.5M est $409.4M | +7.7% |
| Jul 30, 2026 | −$0.04 est −$0.14 | $382.5M est $379.7M | +5.6% |
| May 5, 2026 | −$0.13 est −$0.21 | $348.1M est $345.4M | −4.1% |
| Feb 24, 2026 | −$0.04 est −$0.04 | $367.2M est $362.6M | −6.2% |
| Nov 4, 2025 | −$0.11 est −$0.17 | $334.2M est $328.7M | −7.3% |
| Aug 8, 2025 | −$0.22 est −$0.23 | $314.6M est $297.7M | +3.5% |
| May 6, 2025 | −$0.24 est −$0.26 | $255.7M est $248.1M | +8.7% |
| Feb 24, 2025 | −$0.18 est −$0.15 | $200.7M est $248.8M | −13.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Tempus AI is $89.56, +25.1% from the last close, from 14 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 14 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 3 | Canaccord Genuity | $95 | +32.7% |
| Nov 3 | H.C. Wainwright | $85 | +18.7% |
| Nov 3 | Robert W. Baird | $92 | +28.5% |
| Nov 3 | Mizuho Securities | $120 | +67.6% |
| Nov 2 | Jefferies | $70 | −2.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Tempus AI’s market cap is $12.69B and revenue of $1.51B over the last twelve months.
Coverage of Tempus AI this week reads positive: 2 positive, 2 neutral and 1 negative headlines.
Tempus AI’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 10.6% above |
| PLTRPalantir Technologies | Accumulation | 8.2% below |
| ORCLOracle | Neutral | 27.9% below |
| PANWPalo Alto Networks | Accumulation | 0.6% above |
| CRWDCrowdStrike | Accumulation | 0.9% above |
| CRMSalesforce | Accumulation | 12.1% below |
A peer links to its own page where one exists.
Tempus AI’s market cap is $12.69B at the Nov 13, 2026 close of $71.60, with 177.4M shares outstanding.
The consensus analyst 12-month price target for Tempus AI is $89.56, +25.1% from the last close. Of the 14 firms that rated the stock in the last 90 days, 8 rate it a buy, 6 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Tempus AI is undervalued: the Nov 13, 2026 close of $71.60 is 10.0% below Gekko Fair Value of $79.53. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Tempus AI is expected to report on Feb 23, 2027, after the market closes (100 days away). Analysts expect earnings of $0.06 per share on revenue of $459.2M. Tempus AI beat the earnings estimate in 7 of its last 8 reports, moving 7% on average across the report.
Tempus AI’s 52-week high is $89.09 and its 52-week low is $40.77; it closed at $71.60 on Nov 13, 2026, +0.7% over the past year. Over the last five years the shares peaked at $104.32 on Oct 9, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 1 as mixed (trend) and 1 as a headwind (smart money). The checklist is a description of current data, not a recommendation.
Gekko flagged 6 unusual options signals in Tempus AI over the last 30 days, with $2.39M of flagged premium in calls and $3.16M in puts. The latest, bearish flow, was on Nov 7, 2026 with $316K in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.